80 likes | 255 Views
59-291 Section 2, Lecture 4 Adrenergic Receptor Agonists -termed sympathomimetic 3 Groups: Direct-acting Indirect-acting mixed-acting Direct-acting Subdivided into: -catecholamines -non catecholamines. Catecholamines Naturally occuring- NE, E, dopamine
E N D
59-291 Section 2, Lecture 4 • Adrenergic Receptor Agonists • -termed sympathomimetic • 3 Groups: • Direct-acting • Indirect-acting • mixed-acting • Direct-acting • Subdivided into: • -catecholamines • -non catecholamines
Catecholamines Naturally occuring- NE, E, dopamine Synthetic- isoproterenol and dobutamine These are rapidly inactivated by 2 enzymes found in the gut and liver and in many other tissues: monoamine oxidase (MAO) and catechol-o-methyltransferase (COMT); low oral bioavailabilities and short t ½ therefore must be administered parenterally.
Mechanisms and Effects Catecholamines differ wrt affinities and specificities for the receptors Draw relative response vs log [Catecholamine] plots for the agonists in the box.
Adverse effects: -excessive vasoconstriction leading to ischemia -reduces blood flow to vital organs such as kidneys; cause excessive cardiac stimulation leading to myocardial ischemia ar arrythmias --adrenergic agonists: hyperglycemia undesirable in diabetics Indirect-Acting Amphetamine- induces the release of NE Cocaine-prevents reuptake of NE
Mixed-Acting: the name says it all! activate both α and receptors Ephedrine and Pseudoephedrine vasoconstriction via 1 receptors; useful as nasal decongestants; via bronchodilate Adverse effects: tachycardia, hypertension, urinary retention